Given the fundamental role of AMPK in coordinating cell metabolic balance and survival [45], we demonstrated that ablation of AMPK in CD8+ T cells greatly impairs their anti-tumor functions through promoting cell death under both in vitro and in vivo settings (Figure 5, 6, 7). The gene discussed is CD8A; the disease is neoplasm.